Abstract
ObjectivesMyositis-specific autoantibodies (MSAs) are useful tools for identifying clinically homogeneous subsets and predicting prognosis of patients with idiopathic inflammatory myopathies (IIM) including polymyositis (PM) and dermatomyositis (DM). Recent studies have...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have